Podcasts
When antibiotics stop working: the hidden crisis in plain sight
12 May 2026
Grace Hampson is joined by Lotte Steuten, Deputy CEO of the Office of Health Economics and David McKinney, Co-founder of ARMoR, to dig into the market failures surrounding the AMR crisis and…
Most Favored Nation pricing: what it means for policy, patients and pharma
5 May 2026
US pharmaceutical prices are the highest in the world – President Trump’s Most Favoured Nation (MFN) policy is trying to change that. But what does MFN pricing mean in practice?
Welcome to A Dose of Economics
29 April 2026
When demand for healthcare is growing but budgets are finite, the “how” and “why” of decision-making matters.